THIOPHENE-BASED COMPOUNDS EXHIBITING NOX4 INHIBITORY ACTIVITY AND USE THEREOF IN THERAPY
申请人:Glucox Biotech AB
公开号:EP2825165A1
公开(公告)日:2015-01-21
COMPOUNDS FOR USE IN THERAPY
申请人:Wilcke Mona
公开号:US20150051220A1
公开(公告)日:2015-02-19
A compound of formula (I)
for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.
[EN] THIOPHENE-BASED COMPOUNDS EXHIBITING NOX4 INHIBITORY ACTIVITY AND USE THEREOF IN THERAPY<br/>[FR] COMPOSÉS À BASE DE THIOPHÈNE PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE NOX4 ET LEUR UTILISATION EN THÉRAPIE
申请人:GLUCOX BIOTECH AB
公开号:WO2013135803A1
公开(公告)日:2013-09-19
A compound of formula (I) for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.
Synthesis and Biological Evaluation of Thiophene Derivatives as Acetylcholinesterase Inhibitors
作者:Mohamed M. Ismail、Mona M. Kamel、Lamia W. Mohamed、Samar I. Faggal、Mai A. Galal
DOI:10.3390/molecules17067217
日期:——
A series of new thiophene derivatives has been synthesized using the Gewald protocol. The acetylcholinesterase inhibition activity was assayed according to Ellman’s method using donepezil as reference. Some of the compounds were found to be more potent inhibitors than the reference. 2-(2-(4-(4-Methoxyphenyl)piperazin-1-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide (IIId) showed 60% inhibition, compared to only 40% inhibition by donepezil.